Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Texas Instruments Incorporated (TXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Texas Instruments Incorporated — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while Texas Instruments Incorporated trades at $278.78 (market cap $262.88B). The key difference: Texas Instruments Incorporated is far larger — about 31× Hinge Health Inc. Class A Common Stock's market cap, and Texas Instruments Incorporated pays a 2.11% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Texas Instruments Incorporated for 77 Days on average.
| HNGE | TXN | |
|---|---|---|
Market Cap | $8.48B | $262.88B |
Volume | 879,799 | 5,600,379 |
Sector | Health | Technology |
52-Week High | $105.14 | $332.35 |
52-Week Low | $31.17 | $153.33 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $8.10B | $269.93B |
Dividend Yield | — | 2.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Texas Instruments (TXN) trades at $287.85, up 2.17% with strong technical support at $278 and resistance at $288. The company shows improving fundamentals with Q2 2026 EPS beating expectations at $2.14 versus $1.94, and revenue growth accelerating from $17.7B in 2025 to projected $19.5B in 2026. Operating cash flow strengthened to $7.15B in 2025, supporting consistent dividend payments.
TXN presents a compelling investment case with 47.7% analyst buy ratings and $325 consensus price target offering 13% upside. Key risks include premium valuation (P/E 43.75) and rising debt-to-asset ratio (40.61% in 2025). The data center segment's doubling sales and AI-driven semiconductor demand provide growth catalysts, though competitive pressures and cyclical industry dynamics warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →
